Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients : The INSPIRA pilot cluster-randomized controlled trial
Copyright © 2021 Elsevier Ltd. All rights reserved..
INTRODUCTION: Asthma and COPD are leading causes of disability-adjusted life-years worldwide representing a huge burden on the health system and among patients. One of the reasons for the lack of disease control is poor inhalation technique, with impact on quality of life and symptom control.
OBJECTIVE: To assess the effectiveness of a community pharmacist-led educational intervention on asthma and COPD patients' inhalation technique.
METHODS: The INspira study is a 6-month pilot cluster randomized controlled trial, conducted in community pharmacies of Portugal, enrolling adults aged 18 years or older, with a self-reported diagnosis of asthma or COPD and on inhaled therapy. Pharmacies were randomly allocated to Intervention or Control group. Intervention focused mainly on inhalation technique education via demonstration and repetition. Primary outcome was the proportion of patients scoring 100% in at least one inhaler.
RESULTS: From January to November 2019, 48 pharmacies recruited 201 asthma and COPD patients, of which 132 completed the 6-month follow-up. At the end of follow-up, the odds of intervention group patients score 100% compared to the control group were 5.63 (95% CI, [2.21; 14.35]) in all inhalers in use and 6.77 (95% CI, [2.52; 18.20]) considering at least one inhaler. Intervention group patients reported having a significantly lower number of scheduled appointments compared with the control group (OR = 0.17; 95% CI, [0.037; 0.79]; p = 0.0135). No other significant differences were found between groups.
CONCLUSION: This pilot study suggested that pharmacist interventions can improve patients' inhalation technique, with possible positive impact in healthcare resource use.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:185 |
---|---|
Enthalten in: |
Respiratory medicine - 185(2021) vom: 02. Aug., Seite 106507 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rodrigues, António Teixeira [VerfasserIn] |
---|
Links: |
---|
Themen: |
Asthma |
---|
Anmerkungen: |
Date Completed 04.01.2022 Date Revised 04.01.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.rmed.2021.106507 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM32714162X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM32714162X | ||
003 | DE-627 | ||
005 | 20231225200123.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.rmed.2021.106507 |2 doi | |
028 | 5 | 2 | |a pubmed24n1090.xml |
035 | |a (DE-627)NLM32714162X | ||
035 | |a (NLM)34166959 | ||
035 | |a (PII)S0954-6111(21)00213-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rodrigues, António Teixeira |e verfasserin |4 aut | |
245 | 1 | 0 | |a Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients |b The INSPIRA pilot cluster-randomized controlled trial |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.01.2022 | ||
500 | |a Date Revised 04.01.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Ltd. All rights reserved. | ||
520 | |a INTRODUCTION: Asthma and COPD are leading causes of disability-adjusted life-years worldwide representing a huge burden on the health system and among patients. One of the reasons for the lack of disease control is poor inhalation technique, with impact on quality of life and symptom control | ||
520 | |a OBJECTIVE: To assess the effectiveness of a community pharmacist-led educational intervention on asthma and COPD patients' inhalation technique | ||
520 | |a METHODS: The INspira study is a 6-month pilot cluster randomized controlled trial, conducted in community pharmacies of Portugal, enrolling adults aged 18 years or older, with a self-reported diagnosis of asthma or COPD and on inhaled therapy. Pharmacies were randomly allocated to Intervention or Control group. Intervention focused mainly on inhalation technique education via demonstration and repetition. Primary outcome was the proportion of patients scoring 100% in at least one inhaler | ||
520 | |a RESULTS: From January to November 2019, 48 pharmacies recruited 201 asthma and COPD patients, of which 132 completed the 6-month follow-up. At the end of follow-up, the odds of intervention group patients score 100% compared to the control group were 5.63 (95% CI, [2.21; 14.35]) in all inhalers in use and 6.77 (95% CI, [2.52; 18.20]) considering at least one inhaler. Intervention group patients reported having a significantly lower number of scheduled appointments compared with the control group (OR = 0.17; 95% CI, [0.037; 0.79]; p = 0.0135). No other significant differences were found between groups | ||
520 | |a CONCLUSION: This pilot study suggested that pharmacist interventions can improve patients' inhalation technique, with possible positive impact in healthcare resource use | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Asthma | |
650 | 4 | |a COPD | |
650 | 4 | |a Education | |
650 | 4 | |a Inhalation technique | |
650 | 4 | |a Pharmaceutical care | |
700 | 1 | |a Romano, Sónia |e verfasserin |4 aut | |
700 | 1 | |a Romão, Mariana |e verfasserin |4 aut | |
700 | 1 | |a Figueira, Débora |e verfasserin |4 aut | |
700 | 1 | |a Bulhosa, Carolina |e verfasserin |4 aut | |
700 | 1 | |a Madeira, Anabela |e verfasserin |4 aut | |
700 | 1 | |a Rocha, Luis |e verfasserin |4 aut | |
700 | 1 | |a Alves, José |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Respiratory medicine |d 1993 |g 185(2021) vom: 02. Aug., Seite 106507 |w (DE-627)NLM012605247 |x 1532-3064 |7 nnns |
773 | 1 | 8 | |g volume:185 |g year:2021 |g day:02 |g month:08 |g pages:106507 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rmed.2021.106507 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 185 |j 2021 |b 02 |c 08 |h 106507 |